Anticorps Monoclonal anti-O-GlcNAc
O-GlcNAc Monoclonal Antibody for WB
Hôte / Isotype
Mouse / IgM
Réactivité testée
n/a
Applications
WB
Conjugaison
Non conjugué
CloneNo.
CTD110.6
N° de cat : 65292-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
65292-1-PBS cible O-GlcNAc dans les applications de WB et montre une réactivité avec des échantillons n/a
| Réactivité | n/a |
| Hôte / Isotype | Mouse / IgM |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | s/o |
| Nom complet | O-GlcNAc |
| Symbole du gène | |
| Identification du gène (NCBI) | |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Chromatographie d'affinité thiophilique |
| Tampon de stockage | PBS Only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
O-GlcNAc (O-linked β-N-acetylgulcosamine) is a post-translational modification of serine and threonine residues in proteins. O-GlcNAc modification is abundant in all multicellular eukaryotes, exclusively found on nuclear and cytoplasmic proteins rather than membrane proteins and secretory proteins (PMID: 11269319; 10924527). O-GlcNAc is attached to the protein backbone by enzymatic addition of the N-acetylgulcosamine (GlcNAc) moiety of uridine 5′-diphospho (UDP)-GlcNAc to the hydroxyl oxygen of serines or threonines by the O-linked β-N-acetylgulcosamine transferase (OGT). O-GlcNAc glycosylated proteins can be reversiblely deglycosylated by β-D-N-acetylgulcosaminase (O-GlcNAcase) (PMID: 21526146). O-GlcNAc modification couples many biological processes and plays important roles in development, normal physiology and physiopathology (PMID: 32349769).

